General information
Edanz (www.edanz.com) is a scientific research support service. We are committed to providing innovative solutions to the challenges faced by the international research community, from individual researchers and clinicians to large institutions. Edanz helps scientists reach their goals by providing guidance and support at every stage of research planning, execution, writing, and publication processes.
Edanz Pharma (evidence.edanz.com) supports Medical Affairs teams to plan and execute evidence generation strategies: gap and landscape analyses, publication planning, RWE studies, meta analyses, scientific platform development, manuscript development, congress support, and patient engagement strategies.
Our teams include researchers, journal editors, peer reviewers, publication consultants, medical writers and medical communications specialists.
In 2019 we joined M3 Group (https://corporate.m3.com/); Tokyo Stock Exchange First Section (Securities code 2413).